HuGE Literature Finder
Records
1
-
4
Association of insulin-like growth factor-I receptor polymorphism with colorectal cancer development. Molecular biology reports 2014 Dec 41 (12): 8099-106. Stanilov Noyko S, Karakolev Iliya A, Deliysky Tashko S, Jovchev Jovcho P, Stanilova Spaska |
Activated cMET and IGF1R-driven PI3K signaling predicts poor survival in colorectal cancers independent of KRAS mutational status. PloS one 2014 9 (8): e103551. Lee Jeeyun, Jain Anjali, Kim Phillip, Lee Tani, Kuller Anne, Princen Fred, In-GuDo , Kim Suk Hyeong, Park Joon Oh, Park Young Suk, Singh Sharat, Kim Hee Che |
Is there a role for IGF1R and c-MET pathways in resistance to cetuximab in metastatic colorectal cancer? Clinical colorectal cancer 2011 Dec 10 (4): 325-32. Inno Alessandro, Di Salvatore Mariantonietta, Cenci Tonia, Martini Maurizio, Orlandi Armando, Strippoli Antonia, Ferrara Anna Maria, Bagalà Cinzia, Cassano Alessandra, Larocca Luigi Maria, Barone Car |
Germline polymorphisms in genes involved in the IGF1 pathway predict efficacy of cetuximab in wild-type KRAS mCRC patients. Clinical cancer research : an official journal of the American Association for Cancer Research 2010 Nov 16 (22): 5591-602. Winder Thomas, Zhang Wu, Yang Dongyun, Ning Yan, Bohanes Pierre, Gerger Armin, Wilson Peter M, Pohl Alexandra, Mauro David J, Langer Christiane, Rowinsky Eric K, Lenz Heinz-Jos |
- Page last reviewed:Jul 25, 2022
- Page last updated:Aug 10, 2022
- Content source: